International Journal of Advanced Research in Computer and Communication Engineering

Abstract: Healthcare supply chains have long been viewed as an overly complex, costly ecosystem. Visibility is limited due to data silos and lack of automation, and stringent regulatory certification hinders quality assurance. However, three key vulnerabilities have increasingly attracted attention: (a) dependence on single-source suppliers for critical products, (b) just-in-time inventory management without buffer stock, and (c) fragmented global logistics susceptible to border disruptions during crises. These vulnerabilities do not merely raise costs or reduce service levels; they directly affect patient safety and compromise health systems' resilience.
All supply chains are vulnerable to disruption, whether through natural disasters, infrastructure failure, geopolitical tension or, as demonstrated in the COVID-19 pandemic, global health crises. The pharmaceutical and medical device supply chains are no exceptions. These sectors, hitherto operating under a veneer of relative stability, are now reassessing strategies in order to mitigate catastrophe — and attention is shifting to solutions that go beyond individual enterprise-level adaptations.

Keywords : Healthcare supply chain resilience,Medical supply shortages,Global health crisis preparedness,Pandemic-induced supply disruptions,Critical medical logistics,Pharmaceutical supply chain risk,Medical device availability,Just-in-time inventory failures,Global sourcing dependencies,Health system operational resilience,Emergency procurement strategies,Supply chain risk management in healthcare,Vaccine and PPE distribution challenges,Health infrastructure fragility, Crisis-driven supply chain adaptation.

Downloads: | DOI: 10.17148/IJARCCE.2022.111259